Regional areas and widths of the midsagittal corpus callosum among HIV-infected patients on stable antiretroviral therapies

David F. Tate, Mehul Sampat, Jaroslaw Harezlak, Mark Fiecas, Joseph Hogan, Jeffrey Dewey, Daniel McCaffrey, Daniel Branson, Troy Russell, Jared Conley, Michael Taylor, Giavoni Schifitto, J. Zhong, Eric S. Daar, Jeffrey Alger, Mark Brown, Elyse Singer, T. Campbell, D. McMahon, Y. TsoJanetta Matesan, Scott Letendre, S. Paulose, Michelle Gaugh, C. Tripoli, Constantin Yiannoutsos, Erin D. Bigler, Ronald A. Cohen, Charles R G Guttmann, Bradford Navia

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Recent reports suggest that a growing number of human immunodeficiency virus (HIV)-infected persons show signs of persistent cognitive impairment even in the context of combination antiretroviral therapies (cART). The basis for this finding remains poorly understood as there are only a limited number of studies examining the relationship between CNS injury, measures of disease severity, and cognitive function in the setting of stable disease. This study examined the effects of HIV infection on cerebral white matter using quantitative morphometry of the midsagittal corpus callosum (CC) in 216 chronically infected participants from the multisite HIV Neuroimaging Consortium study currently receiving cART and 139 controls. All participants underwent MRI assessment, and HIV-infected subjects also underwent measures of cognitive function and disease severity. The midsagittal slice of the CC was quantified using two semi-automated procedures. Group comparisons were accomplished using ANOVA, and the relationship between CC morphometry and clinical covariates (current CD4, nadir CD4, plasma and CSF HIV RNA, duration of HIV infection, age, and ADC stage) was assessed using linear regression models. HIV-infected patients showed significant reductions in both the area and linear widths for several regions of the CC. Significant relationships were found with ADC stage and nadir CD4 cell count, but no other clinical variables. Despite effective treatment, significant and possibly irreversible structural loss of the white matter persists in the setting of chronic HIV disease. A history of advanced immune suppression is a strong predictor of this complication and suggests that antiretroviral intervention at earlier stages of infection may be warranted.

Original languageEnglish
Pages (from-to)368-379
Number of pages12
JournalJournal of NeuroVirology
Volume17
Issue number4
DOIs
StatePublished - Aug 2011

Fingerprint

Corpus Callosum
HIV
Virus Diseases
Therapeutics
Cognition
Linear Models
CD4 Lymphocyte Count
Neuroimaging
Analysis of Variance
RNA
Wounds and Injuries
Infection

Keywords

  • CART
  • Corpus callosum
  • HIV
  • Nadir CD4
  • White matter

ASJC Scopus subject areas

  • Virology
  • Clinical Neurology
  • Cellular and Molecular Neuroscience
  • Neurology

Cite this

Regional areas and widths of the midsagittal corpus callosum among HIV-infected patients on stable antiretroviral therapies. / Tate, David F.; Sampat, Mehul; Harezlak, Jaroslaw; Fiecas, Mark; Hogan, Joseph; Dewey, Jeffrey; McCaffrey, Daniel; Branson, Daniel; Russell, Troy; Conley, Jared; Taylor, Michael; Schifitto, Giavoni; Zhong, J.; Daar, Eric S.; Alger, Jeffrey; Brown, Mark; Singer, Elyse; Campbell, T.; McMahon, D.; Tso, Y.; Matesan, Janetta; Letendre, Scott; Paulose, S.; Gaugh, Michelle; Tripoli, C.; Yiannoutsos, Constantin; Bigler, Erin D.; Cohen, Ronald A.; Guttmann, Charles R G; Navia, Bradford.

In: Journal of NeuroVirology, Vol. 17, No. 4, 08.2011, p. 368-379.

Research output: Contribution to journalArticle

Tate, DF, Sampat, M, Harezlak, J, Fiecas, M, Hogan, J, Dewey, J, McCaffrey, D, Branson, D, Russell, T, Conley, J, Taylor, M, Schifitto, G, Zhong, J, Daar, ES, Alger, J, Brown, M, Singer, E, Campbell, T, McMahon, D, Tso, Y, Matesan, J, Letendre, S, Paulose, S, Gaugh, M, Tripoli, C, Yiannoutsos, C, Bigler, ED, Cohen, RA, Guttmann, CRG & Navia, B 2011, 'Regional areas and widths of the midsagittal corpus callosum among HIV-infected patients on stable antiretroviral therapies', Journal of NeuroVirology, vol. 17, no. 4, pp. 368-379. https://doi.org/10.1007/s13365-011-0033-6
Tate, David F. ; Sampat, Mehul ; Harezlak, Jaroslaw ; Fiecas, Mark ; Hogan, Joseph ; Dewey, Jeffrey ; McCaffrey, Daniel ; Branson, Daniel ; Russell, Troy ; Conley, Jared ; Taylor, Michael ; Schifitto, Giavoni ; Zhong, J. ; Daar, Eric S. ; Alger, Jeffrey ; Brown, Mark ; Singer, Elyse ; Campbell, T. ; McMahon, D. ; Tso, Y. ; Matesan, Janetta ; Letendre, Scott ; Paulose, S. ; Gaugh, Michelle ; Tripoli, C. ; Yiannoutsos, Constantin ; Bigler, Erin D. ; Cohen, Ronald A. ; Guttmann, Charles R G ; Navia, Bradford. / Regional areas and widths of the midsagittal corpus callosum among HIV-infected patients on stable antiretroviral therapies. In: Journal of NeuroVirology. 2011 ; Vol. 17, No. 4. pp. 368-379.
@article{be46f966ba204d018744282edd786f7d,
title = "Regional areas and widths of the midsagittal corpus callosum among HIV-infected patients on stable antiretroviral therapies",
abstract = "Recent reports suggest that a growing number of human immunodeficiency virus (HIV)-infected persons show signs of persistent cognitive impairment even in the context of combination antiretroviral therapies (cART). The basis for this finding remains poorly understood as there are only a limited number of studies examining the relationship between CNS injury, measures of disease severity, and cognitive function in the setting of stable disease. This study examined the effects of HIV infection on cerebral white matter using quantitative morphometry of the midsagittal corpus callosum (CC) in 216 chronically infected participants from the multisite HIV Neuroimaging Consortium study currently receiving cART and 139 controls. All participants underwent MRI assessment, and HIV-infected subjects also underwent measures of cognitive function and disease severity. The midsagittal slice of the CC was quantified using two semi-automated procedures. Group comparisons were accomplished using ANOVA, and the relationship between CC morphometry and clinical covariates (current CD4, nadir CD4, plasma and CSF HIV RNA, duration of HIV infection, age, and ADC stage) was assessed using linear regression models. HIV-infected patients showed significant reductions in both the area and linear widths for several regions of the CC. Significant relationships were found with ADC stage and nadir CD4 cell count, but no other clinical variables. Despite effective treatment, significant and possibly irreversible structural loss of the white matter persists in the setting of chronic HIV disease. A history of advanced immune suppression is a strong predictor of this complication and suggests that antiretroviral intervention at earlier stages of infection may be warranted.",
keywords = "CART, Corpus callosum, HIV, Nadir CD4, White matter",
author = "Tate, {David F.} and Mehul Sampat and Jaroslaw Harezlak and Mark Fiecas and Joseph Hogan and Jeffrey Dewey and Daniel McCaffrey and Daniel Branson and Troy Russell and Jared Conley and Michael Taylor and Giavoni Schifitto and J. Zhong and Daar, {Eric S.} and Jeffrey Alger and Mark Brown and Elyse Singer and T. Campbell and D. McMahon and Y. Tso and Janetta Matesan and Scott Letendre and S. Paulose and Michelle Gaugh and C. Tripoli and Constantin Yiannoutsos and Bigler, {Erin D.} and Cohen, {Ronald A.} and Guttmann, {Charles R G} and Bradford Navia",
year = "2011",
month = "8",
doi = "10.1007/s13365-011-0033-6",
language = "English",
volume = "17",
pages = "368--379",
journal = "Journal of NeuroVirology",
issn = "1355-0284",
publisher = "Springer New York",
number = "4",

}

TY - JOUR

T1 - Regional areas and widths of the midsagittal corpus callosum among HIV-infected patients on stable antiretroviral therapies

AU - Tate, David F.

AU - Sampat, Mehul

AU - Harezlak, Jaroslaw

AU - Fiecas, Mark

AU - Hogan, Joseph

AU - Dewey, Jeffrey

AU - McCaffrey, Daniel

AU - Branson, Daniel

AU - Russell, Troy

AU - Conley, Jared

AU - Taylor, Michael

AU - Schifitto, Giavoni

AU - Zhong, J.

AU - Daar, Eric S.

AU - Alger, Jeffrey

AU - Brown, Mark

AU - Singer, Elyse

AU - Campbell, T.

AU - McMahon, D.

AU - Tso, Y.

AU - Matesan, Janetta

AU - Letendre, Scott

AU - Paulose, S.

AU - Gaugh, Michelle

AU - Tripoli, C.

AU - Yiannoutsos, Constantin

AU - Bigler, Erin D.

AU - Cohen, Ronald A.

AU - Guttmann, Charles R G

AU - Navia, Bradford

PY - 2011/8

Y1 - 2011/8

N2 - Recent reports suggest that a growing number of human immunodeficiency virus (HIV)-infected persons show signs of persistent cognitive impairment even in the context of combination antiretroviral therapies (cART). The basis for this finding remains poorly understood as there are only a limited number of studies examining the relationship between CNS injury, measures of disease severity, and cognitive function in the setting of stable disease. This study examined the effects of HIV infection on cerebral white matter using quantitative morphometry of the midsagittal corpus callosum (CC) in 216 chronically infected participants from the multisite HIV Neuroimaging Consortium study currently receiving cART and 139 controls. All participants underwent MRI assessment, and HIV-infected subjects also underwent measures of cognitive function and disease severity. The midsagittal slice of the CC was quantified using two semi-automated procedures. Group comparisons were accomplished using ANOVA, and the relationship between CC morphometry and clinical covariates (current CD4, nadir CD4, plasma and CSF HIV RNA, duration of HIV infection, age, and ADC stage) was assessed using linear regression models. HIV-infected patients showed significant reductions in both the area and linear widths for several regions of the CC. Significant relationships were found with ADC stage and nadir CD4 cell count, but no other clinical variables. Despite effective treatment, significant and possibly irreversible structural loss of the white matter persists in the setting of chronic HIV disease. A history of advanced immune suppression is a strong predictor of this complication and suggests that antiretroviral intervention at earlier stages of infection may be warranted.

AB - Recent reports suggest that a growing number of human immunodeficiency virus (HIV)-infected persons show signs of persistent cognitive impairment even in the context of combination antiretroviral therapies (cART). The basis for this finding remains poorly understood as there are only a limited number of studies examining the relationship between CNS injury, measures of disease severity, and cognitive function in the setting of stable disease. This study examined the effects of HIV infection on cerebral white matter using quantitative morphometry of the midsagittal corpus callosum (CC) in 216 chronically infected participants from the multisite HIV Neuroimaging Consortium study currently receiving cART and 139 controls. All participants underwent MRI assessment, and HIV-infected subjects also underwent measures of cognitive function and disease severity. The midsagittal slice of the CC was quantified using two semi-automated procedures. Group comparisons were accomplished using ANOVA, and the relationship between CC morphometry and clinical covariates (current CD4, nadir CD4, plasma and CSF HIV RNA, duration of HIV infection, age, and ADC stage) was assessed using linear regression models. HIV-infected patients showed significant reductions in both the area and linear widths for several regions of the CC. Significant relationships were found with ADC stage and nadir CD4 cell count, but no other clinical variables. Despite effective treatment, significant and possibly irreversible structural loss of the white matter persists in the setting of chronic HIV disease. A history of advanced immune suppression is a strong predictor of this complication and suggests that antiretroviral intervention at earlier stages of infection may be warranted.

KW - CART

KW - Corpus callosum

KW - HIV

KW - Nadir CD4

KW - White matter

UR - http://www.scopus.com/inward/record.url?scp=80054738618&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80054738618&partnerID=8YFLogxK

U2 - 10.1007/s13365-011-0033-6

DO - 10.1007/s13365-011-0033-6

M3 - Article

C2 - 21556960

AN - SCOPUS:80054738618

VL - 17

SP - 368

EP - 379

JO - Journal of NeuroVirology

JF - Journal of NeuroVirology

SN - 1355-0284

IS - 4

ER -